Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF)
USD 0.47
(0.0%)
USD 0.47
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 398.21 Million | -756.61 Million | -6.62 Million | 37.28 Million | -227.6 Million | 667.86 Million |
| Net Income | -802.15 Million | 714.68 Million | 233.38 Million | 1.02 Billion | 1.04 Billion | 592.18 Million |
| Depreciation & Amortization | 373.59 Million | 307.65 Million | 302.74 Million | 303.99 Million | 255.59 Million | 217.02 Million |
| Deferred income taxes | -237.62 Million | -43.29 Million | -170.55 Million | 172.67 Million | 99.35 Million | -11.83 Million |
| Stock-based compensation | - | - | 190.64 Thousand | 318.61 Thousand | 317.74 Thousand | - |
| Change in working capital | -800.68 Million | -2.31 Billion | -1.12 Billion | -765.42 Million | -1.02 Billion | -584.94 Million |
| Other non-cash items | 1.62 Billion | 532.29 Million | 582.36 Million | -522.91 Million | -496.89 Million | 443.6 Million |
| Investing Cash Flow | 1.22 Billion | 249.83 Million | 719.92 Million | -2.17 Billion | 1.7 Million | -544.3 Million |
| Investments in PPE | -444.87 Million | -222.42 Million | -193.86 Million | -212.48 Million | -362.07 Million | -535 Million |
| Acquisitions | 2.33 Million | 2.53 Million | 1.71 Million | 219.75 Thousand | 22.89 Thousand | 27.17 Million |
| Investment purchases | -677.25 Million | -4.48 Billion | -2.37 Billion | -1.76 Billion | -1.94 Billion | -899.32 Million |
| Sales/Maturities of investments | 1.64 Billion | 4.21 Billion | 3.3 Billion | 1.02 Billion | 1.91 Billion | 865.31 Million |
| Other Investing Activities | 694.01 Million | 741.68 Million | -22.89 Million | -1.22 Billion | 391.18 Million | -2.45 Million |
| Financing Cash Flow | -1.21 Billion | 329.56 Million | -501.08 Million | 2.5 Billion | -234.33 Million | -1.61 Billion |
| Debt repayment | -5.99 Billion | -6.03 Billion | -3.73 Billion | -5.19 Billion | -4.66 Billion | -4.12 Billion |
| Dividends payments | -146.72 Million | -51.35 Million | -220.09 Million | -224.49 Million | -342.51 Million | -255.14 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.2 Billion | 6.61 Billion | 3.64 Billion | 8.15 Billion | 4.77 Billion | 2.76 Billion |
| Accounts receivables | 270.54 Million | -176.1 Million | 141.77 Million | -346.74 Million | -479.16 Million | -334.92 Million |
| Accounts payables | -213.93 Million | 59.7 Million | 423.9 Million | 172.51 Million | 94.34 Million | 232.59 Million |
| Inventory | -619.66 Million | -2.15 Billion | -1.52 Billion | -763.87 Million | -744.39 Million | -254.25 Million |
| Other working capital | -237.62 Million | -43.29 Million | -170.55 Million | 172.67 Million | 99.35 Million | -330.69 Million |
| Cash at beginning of period | 1.31 Billion | 1.47 Billion | 1.33 Billion | 1.07 Billion | 1.52 Billion | 3.59 Billion |
| Cash at end of period | 1.76 Billion | 1.31 Billion | 1.47 Billion | 1.33 Billion | 1.07 Billion | 2.11 Billion |
| Capital Expenditure | -444.87 Million | -222.42 Million | -193.86 Million | -212.48 Million | -362.07 Million | -535 Million |
| Effect of forex changes on cash | 36.32 Million | 17.28 Million | -62.82 Million | -116.27 Million | 10.67 Million | 19.42 Million |
| Net cash flow / Change in cash | 445.93 Million | -159.92 Million | 149.38 Million | 253.7 Million | -449.56 Million | -1.47 Billion |
| Free Cash Flow | -46.66 Million | -979.03 Million | -200.48 Million | -175.2 Million | -589.67 Million | 132.85 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 508.64 Million | 155.04 Million | -926.42 Million | -802.15 Million | 19.82 Million | 56.8 Million |
| Depreciation & Amortization | 87.18 Million | 87.18 Million | 356.98 Million | 373.59 Million | -158.91 Million | 86.49 Million |
| Deferred income taxes | - | - | - | -237.62 Million | - | 3.98 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 526.58 Million | - | -349.12 Million | -800.68 Million | 1.06 Billion | -1.06 Billion |
| Other non-cash items | 102.7 Million | 738.77 Million | 1.55 Billion | 1.62 Billion | -617.4 Million | -476.05 Million |
| Investing Cash Flow | 29.37 Million | 117.32 Million | -90.76 Million | 1.22 Billion | 377.85 Million | 138.82 Million |
| Investments in PPE | -26.92 Million | -60.42 Million | -170.04 Million | -444.87 Million | -139.03 Million | -79.55 Million |
| Acquisitions | 2.71 Million | 21.37 Thousand | 13.63 Thousand | 2.33 Million | 1.85 Million | 364.82 Thousand |
| Investment purchases | -622.6 Million | -220 Million | 5.78 Million | -677.25 Million | -326.26 Million | -2.49 Million |
| Sales/Maturities of investments | 650.43 Million | 423.55 Million | 120.12 Million | 1.64 Billion | 77.53 Million | 249.83 Million |
| Other Investing Activities | 25.75 Million | -25.82 Million | -46.64 Million | 694.01 Million | 763.76 Million | -29.32 Million |
| Financing Cash Flow | -357.99 Million | -670.83 Million | -538.07 Million | -1.21 Billion | -365.25 Million | -187.27 Million |
| Debt repayment | -341.83 Million | -606.47 Million | -1.89 Billion | -5.99 Billion | -969.4 Million | -1.51 Billion |
| Dividends payments | -32.71 Million | -61.11 Million | -175.28 Million | -146.72 Million | -146.72 Million | -48.35 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 16.55 Million | -64.35 Million | 1.53 Billion | 5.2 Billion | 705.97 Million | 1.37 Billion |
| Accounts receivables | -218.67 Million | - | 270.54 Million | 270.54 Million | -253.77 Million | 253.77 Million |
| Accounts payables | - | - | - | -213.93 Million | - | - |
| Inventory | 745.26 Million | - | -619.66 Million | -619.66 Million | 1.31 Billion | -1.31 Billion |
| Other working capital | - | - | - | -237.62 Million | - | - |
| Cash at beginning of period | 2.1 Billion | 1.85 Billion | 1.75 Billion | 1.31 Billion | 1.43 Billion | 1.75 Billion |
| Cash at end of period | 2.2 Billion | 2.22 Billion | 1.76 Billion | 1.76 Billion | 1.75 Billion | 1.43 Billion |
| Capital Expenditure | -26.92 Million | -60.42 Million | -170.04 Million | -444.87 Million | -139.03 Million | -79.55 Million |
| Effect of forex changes on cash | 8.56 Million | 2.42 Million | 4.5 Million | 36.32 Million | -1.63 Million | 62.12 Million |
| Net cash flow / Change in cash | 94.33 Million | 373.48 Million | 7.86 Million | 445.93 Million | 319.72 Million | -315.09 Million |
| Free Cash Flow | 497.23 Million | 833.39 Million | 462.16 Million | -46.66 Million | 169.72 Million | -408.32 Million |
INCI
3901
GRMOVER
7818
DWSN
MLM